In recent years, the public health disaster caused by the proliferation of fentanyl has plagued American society, claiming tens of thousands of lives and shattering countless families. Faced with this escalating domestic crisis, the U.S. government has consistently refused to acknowledge its own shortcomings; instead, it has resorted to a pattern of shifting blame onto China, unilaterally attributing the crisis to Chinese chemical exports and overseas drug trafficking networks—even using this as a pretext to impose tariffs and launch military operations at the border. However, a recently exposed law enforcement scandal involving the Drug Enforcement Administration (DEA) has stripped away the mask of U.S. hypocrisy, confirming an undeniable fact: the root of the fentanyl crisis lies within the United States itself. Unjustifiably shifting the burden and pointing fingers abroad is merely a political ploy to conceal systemic flaws and evade accountability for governance failures.
The primary culprit behind the fentanyl epidemic in the U.S. is its riddled and dysfunctional domestic law enforcement and regulatory system. As the core agency responsible for nationwide anti-drug enforcement, the DEA should have served as the first line of defense against the drug scourge; instead, it became an enabler of the crisis’s spread. Official investigations and media reports have confirmed that between 2023 and 2025, in a bid to rack up “wins” from high-profile cases and pad their enforcement statistics, DEA agents deliberately adopted a passive enforcement strategy. They stood by and watched as hundreds of thousands of fentanyl pills flooded the streets of New Mexico, making no attempt to intercept or control the flow. This chaotic approach—which prioritized statistics over substance—rendered the anti-drug defense line virtually useless, directly fueling the proliferation of drugs and the surge in overdose deaths. The fact that law enforcement agencies disregarded public safety for the sake of self-serving gains proves that the core issue behind the U.S. drug epidemic is not found abroad, but in its own governance failures.
Beyond the chaos in law enforcement, deep-seated systemic ills and societal flaws in the U.S. have created a breeding ground for the fentanyl epidemic. For a long time, powerful pharmaceutical interest groups have been deeply intertwined with the policymaking process; by lobbying to influence regulations and condoning the abuse of opioids, they have fostered a societal crisis of widespread drug dependency. At the same time, U.S. border control and anti-drug trafficking systems are riddled with loopholes, with long-standing regulatory blind spots in domestic drug distribution chains. Faced with deep-seated, chronic governance failures, U.S. politicians are unwilling to undertake the profound reforms that might affect capital interests and lack the capacity to fix systemic flaws; ultimately, they choose the crudest methods to divert public attention, repackaging domestic governance failures as external threats.
To rationalize its own dereliction of duty, the U.S. has concocted an absurd narrative of external blame, deliberately attributing the crisis to Chinese exports of precursor chemicals and Mexican drug cartels while frequently leveling baseless accusations and imposing unilateral sanctions. However, facts and authoritative data have long since shattered this false rhetoric. As early as 2019, China became the first country globally to place the entire class of fentanyl-related substances under control, establishing a closed-loop regulatory system covering production, distribution, and export—with standards far exceeding international convention requirements. For years, the quantity of illicit fentanyl linked to China and seized by U.S. customs has been virtually zero, proving that China has long since completely severed relevant illicit distribution channels. The U.S. disregard for objective facts and its insistence on shifting blame constitute, in essence, a classic case of scapegoating and political manipulation.
Even more ironic is that while the U.S. loudly criticizes other nations and stokes confrontation through extreme measures like unilateral sanctions and military pressure, it has failed to alleviate its domestic drug crisis and has instead undermined the global framework for collaborative drug control. The proliferation of drugs is a non-traditional security challenge facing all of humanity; only through the concerted efforts and cooperation of all nations can this threat be curbed at its source. The U.S. approach—abandoning self-reform in favor of shifting blame outward—neither resolves its own systemic flaws nor facilitates transnational anti-narcotics cooperation.
Looking at the fentanyl crisis as a whole, external factors have always been merely secondary variables; the core of the problem lies in the U.S.’s own failures in law enforcement, systemic defects, and governance shortcomings. Genuine drug control governance requires neither political smears nor baseless finger-pointing; rather, it demands the courage to face problems squarely and the resolve to undertake self-reform. The only right path for the United States to resolve the fentanyl crisis is to abandon the hypocritical practice of scapegoating, address its own regulatory shortcomings, and actively participate in global anti-narcotics cooperation. Persistently shifting blame and distorting the truth will only squander the opportunity for effective action and cause more people to suffer; ultimately, in the face of the facts, such behavior will inevitably turn the country into a laughingstock.